Global Diagnostics and monitoring automation Market Research Report
- Report Code: DI 1000
- Publish Date: Upcoming
The Global Diagnostic and Monitoring Automation Market, mainly driven by increasing need for accuracy, need for reproducibility and rise in labor cost was valued at $22,026 million in 2013 and is expected to reach $29,230 million by 2018, at a CAGR of 5.8%. The diagnostic and monitoring automation market is the largest segment of $44,077 million medical automation market.
The report “Diagnostic and monitoring Automation Market forecast, 2012-2018”analyzes the market by 3 segments such as automated imaging market, automated image analysis market and point of care market. All of these segments experienced a positive growth till 2013 as it reduces human involvement there by reducing labor cost and people’s growing concern for patient safety. With a market value of $8,071 million, in 2013, automated imaging market has been contributing around 35% towards total Diagnostic and Monitoring Automation Market. The large share of this segment can be attributed to the wide usage of automated medical imaging devices by hospitals and imaging centers. In terms of growth, automated imaging analysis market is showing the fastest growth.
Asian diagnostic and monitoring automation market is estimated to be $5,742 million by 2018. Emerging Asian economies will be on the priority list for most automated device manufacturing companies. The market is driven by increasing labor cost and rising research related activities in Asia. This is compelling the Asian medical industry to opt for automation. Also the point of care segment is seeing increase in growth due to increase in diabetic patient pool in Asia.
In North America (US, Canada and Mexico) and Europe (Germany, France, Italy, Spain, UK) the diagnostic and monitoring automation market is mainly driven because of the need for accuracy and efficiency in both monetary terms and reduced suffering or pain for a patient. Further, collaboration amongst prominent players is driving the automated medical imaging market in North America and Europe. Investment in R&D, in this sector is a major driver for diagnostic and monitoring market.
The increase in lifestyle diseases boosts the growth of diagnostic and monitoring markets across countries. In the U.S, over 30% of the adult population has hypertension, affecting 65 million individuals, and at least as many have pre-hypertension. Prevalence of hypertension has been reported to be low in the U.S. and Canada (27%) than in Europe (38–55%).
The report also provides an extensive competitive landscaping of companies operating in this market. The main companies operating in Diagnostic and Monitoring automation market and extensively covered in this report are GE Healthcare, Philips Healthcare, Siemens Healthcare, AGFA healthcare, Insight Pharmaceuticals and Konica Minolta Medical
Segment and country specific Company shares, News & Deals, M&A, segment specific pipeline products, product approvals and product recalls of the major companies have been detailed.
Customization Options:
The Market data enables you to customize the MMM assessments that meet your company’s specific needs. Customize to get comprehensive industry standard and deep dive analysis of the following parameters:
Product Analysis
- Usage pattern (in-depth trend analysis) of products (Segment wise)
- Product Matrix which gives a detailed comparison of product portfolio of each company mapped at country and sub segment level
- End-user Adoption rate analysis of the products (Segment wise and Country wise)
- Comprehensive coverage of Product approvals, Pipeline products and Product recalls
Epidemiology Data
- Country specific Prevalence of Diabetes, Hypertension, Brain Tumors
- Country specific Patient pool of Diabetes, Hypertension and chronic diseases
- Disease progression (Pattern analysis)
Surgeons/Physicians Perception Analysis
- Fast turn-around analysis of Surgeons response to market events and trends
- Pattern analysis of usage of diagnostic and monitoring automation products by Physicians
- Surgeons opinion about products from different companies
- Surgeons qualitative inputs on epidemiology data
Brand/Product Perception Matrix
- Comprehensive study of customers perception and behavior through our inbuilt social connect tool checking the virality and tonality of blogs
- Analysis of overall brand usage and familiarity and brand advocacy distribution (Detractor/Neutral/Familiar)
Alternative Products: Impact analysis
MMM’s Healthcare Decision Making Quadrant It is an innovative and useful quadrant for vendors who wish to analyze the potential growth markets based on parameters like Patient dynamics (Patient pool and epidemiology of disease) and Macroeconomic indicators (Number of Hospitals, labs, research laboratories, Diagnostic centers, reimbursement scenario and healthcare expenditure)
1 Introduction
1.1 Analyst Insights
1.2 Market Definitions
1.3 Market Segmentation & Aspects Covered
1.4 Research Methodology
2 Executive Summary
3 Market Overview
4 By Endusers
4.1 Hospitals
4.2 Research labs
4.3 Home
4.4 Pharmaceutical companies
5 By Geographies
5.1 North America
5.2 Europe
5.3 Asia
5.4 Rest of World
Please fill in the form below to receive a free copy of the Summary of this Report
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
| PRODUCT TITLE | PUBLISHED | |
|---|---|---|
|
|
North American Diagnostic and Monitoring Automation Market The North American diagnostic and monitoring automation market, mainly driven by the increasing need for accuracy and reproducibility, and rise in labor cost, was valued at $10.9 billion in 2013 and is expected to reach $13.9 billion by 2018, at a CAGR of 4.9% during the forecast period. The report on this market analyzes it under three segments: automated imaging market, automated image analysis market, and point of care market. The main companies operating in this market and extensively covered in this report are Philips Healthcare, Siemens Healthcare, Agfa healthcare, Insight Pharmaceuticals, LLC, Konica Minolta Medical Imaging, GE Healthcare, and others. |
Upcoming |
|
|
European Diagnostic and Monitoring Automation Market The European diagnostic and monitoring automation market, mainly driven by the increasing need for accuracy and reproducibility, and rise in labor cost, was valued at $5.3 billion in 2013 and is expected to reach $6.8 billion by 2018, at a CAGR of 5.0% during the forecast period. The report on this market analyzes it under three segments: automated imaging market, automated image analysis market, and point of care market. The main companies operating in this market and extensively covered in this report are Philips Healthcare, Siemens Healthcare, Agfa healthcare, Insight Pharmaceuticals, LLC, Konica Minolta Medical Imaging, GE Healthcare, and others. |
Upcoming |
|
|
Asian Diagnostic and Monitoring Automation Market The Asian diagnostic and monitoring automation market was valued at $3.7 billion in 2013 and is expected to reach $5.7 billion by 2018, at a CAGR of 8.6%. The report on this market analyzes it under three segments: automated imaging market, automated image analysis market, and point of care market. The main companies operating in this market and extensively covered in this report are Philips Healthcare, Siemens Healthcare, Agfa healthcare, Insight Pharmaceuticals, LLC, Konica Minolta Medical Imaging, GE Healthcare, and others. |
Upcoming |
